Combining depressant drugs multiplies risks
Health Canada has asked pharmaceutical companies to put stronger safety labels on benzodiazepines and other sedative drugs prescribed for sleep and anxiety disorder to better reflect their serious risks.
Doctors have long prescribed benzodiazepines such as lorazepam (brand name Ativan), alprazolam (Xanax) and clonazepam (Klonopin) in the short term to treat anxiety, insomnia and certain seizure disorders. But people can become dependent and an overdose can result in a coma or even death.
Cheyenne Johnson of the BC Centre on Substance Use said benzodiazepines are frequently misused with opioids, which can be fatal.
Click here for the full story on CBC News.